Next Article in Journal
Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016–2021
Next Article in Special Issue
Antimicrobial Activities of Secondary Metabolites from Model Mosses
Previous Article in Journal
The Bacterial Urban Resistome: Recent Advances
Previous Article in Special Issue
New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Secondary Metabolite Variation and Bioactivities of Two Marine Aspergillus Strains in Static Co-Culture Investigated by Molecular Network Analysis and Multiple Database Mining Based on LC-PDA-MS/MS

1
College of Food Science and Technology, Guangdong Ocean University, Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Provincial Engineering Technology Research Center of Seafood, Shenzhen Institute of Guangdong Ocean University, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, Research Institute for Marine Drugs and Nutrition, Guangdong Ocean University, Zhanjiang 524088, China
2
Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China
3
Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, and the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(4), 513; https://doi.org/10.3390/antibiotics11040513
Submission received: 19 February 2022 / Revised: 30 March 2022 / Accepted: 6 April 2022 / Published: 12 April 2022
(This article belongs to the Special Issue Antimicrobial Natural Products)

Abstract

:
Co-culture is known as an efficient way to explore the metabolic potential of fungal strains for new antibiotics and other therapeutic agents that could counter emerging health issues. To study the effect of co-culture on the secondary metabolites and bioactivities of two marine strains, Aspergillus terreus C23-3 and Aspergillus. unguis DLEP2008001, they were co-cultured in live or inactivated forms successively or simultaneously. The mycelial morphology and high-performance thin layer chromatography (HPTLC) including bioautography of the fermentation extracts were recorded. Furthermore, the agar cup-plate method was used to compare the antimicrobial activity of the extracts. Based on the above, liquid chromatography-photodiode array-tandem mass spectrometry (LC-PDA-MS/MS) together with Global Natural Products Social molecular networking (GNPS) and multiple natural products database mining were used to further analyze their secondary metabolite variations. The comprehensive results showed the following trends: (1) The strain first inoculated will strongly inhibit the growth and metabolism of the latter inoculated one; (2) Autoclaved A. unguis exerted a strong inducing effect on later inoculated A. terreus, while the autoclaved A. terreus showed high stability of its metabolites and still potently suppressed the growth and metabolism of A. unguis; (3) When the two strains are inoculated simultaneously, they both grow and produce metabolites; however, the A. terreus seemed to be more strongly induced by live A. unguis and this inducing effect surpassed that of the autoclaved A. unguis. Under some of the conditions, the extracts showed higher antimicrobial activity than the axenic cultures. Totally, A. unguis was negative in response but potent in stimulating its rival while A. terreus had the opposite effect. Fifteen MS detectable and/or UV active peaks showed different yields in co-cultures vs. the corresponding axenic culture. GNPS analysis assisted by multiple natural products databases mining (PubChem, Dictionary of Natural Products, NPASS, etc.) gave reasonable annotations for some of these peaks, including antimicrobial compounds such as unguisin A, lovastatin, and nidulin. However, some of the peaks were correlated with antagonistic properties and remain as possible novel compounds without mass or UV matching hits from any database. It is intriguing that the two strains both synthesize chemical ‘weapons’ for antagonism, and that these are upregulated when needed in competitive co-culture environment. At the same time, compounds not useful in this antagonistic setting are downregulated in their expression. Some of the natural products produced during antagonism are unknown chlorinated metabolites and deserve further study for their antimicrobial properties. In summary, this study disclosed the different responses of two Aspergillus strains in co-culture, revealed their metabolic variation, and displayed new opportunities for antibiotic discovery.

1. Introduction

The ocean supports an amazing variety of marine life and is a crucial part of the biosphere. Marine organisms, including microbes, have developed complex metabolic mechanisms to adapt themselves to the unique environment of high salinity, high pressure, low oxygen, and oligotrophy. As a result, secondary metabolites (SMs) with novel structures and rich activities are produced and provide a rich source of drug lead compounds [1]. Although medical sciences have made significant progress, infectious diseases caused by bacteria, fungi, and viruses still pose a substantial threat to public health. Due to the development of antibiotic resistance, finding new antibiotics remains an essential task for scientists worldwide. Nevertheless, most of the current antibacterial agents derived from natural products were isolated from terrestrial sources, while marine organisms are still primarily untapped resources for new biologically active natural products, and especially antibiotics [2].
Previous studies have shown that fungi contain many diverse biosynthetic gene clusters that encode for secondary metabolites, but under artificial culture conditions in the laboratory, most fungal functional gene clusters are silent (i.e., not expressed). The methods for enriching the diversity of expressed fungal metabolites include changing the composition of the medium, changing the environmental conditions, adding epigenetic modifiers, and co-cultivating with other fungi or bacteria [3,4,5]. Specifically, the co-cultivation of microorganisms from different sources often creates competition and antagonism. To compete for the limited natural resources in such an environment, or for living space or to maintain information transmission between species, the microbes often produce secondary metabolites that are not produced when cultured separately [6].
Mass spectrometry (MS)-based metabolomics is increasingly playing an important role in efficient natural products studies. These approaches enable the accurate offline and online comparison of constituent differences among samples including big data samples. However, these data sets are often too large for manual analysis as more than 1000 MS/MS spectra can be collected from just one extract sample. Global Natural Products Social molecular networking (GNPS) is a data-driven open platform for the storage, analysis, and dissemination of MS/MS spectra. It provides the ability to visualize data sets from different users and compare these with all publicly available reference spectra to annotate known molecules and discover putative analogs [7]. For example, Oppong-Danquah. et al. used a GNPS molecular networking-based screening method to annotate metabolites with crop protection activity in co-cultures of several marine fungi, significantly improving the efficiency of discovery and identification of trace novel natural products [8]. GNPS is a continuously developing platform for accurate dereplication and annotation tasks, and thus is best complemented with other approaches at the present time.
In preliminary studies, our laboratory obtained a marine Aspergillus terreus strain C23-3 from a coral collected in Xuwen Natural Reserve of South China Sea and a marine A. unguis strain DLEP2008001 from a seaweed collected at the intertidal zone of Dalian City by the Yellow Sea of Northern China. Intriguingly, our previous research and the reports from other groups indicated that both these two species/strains can produce potent antibiotics as well as other bioactive compounds. For example, A. terreus produces butyrolactones showing antibacterial, antitumor, antioxidant, antiviral, enzymes (glucosidase, glucuronidase, and cyclin-dependent protein kinase 5) inhibitory, neuroprotective, anti(-neuro-)inflammatory, and axonal growth promoting activities [9,10,11,12,13,14], as well as lipid lowering lovastatins and acetylcholinesterase (AChE) inhibitory territrems [15,16]. As for A. unguis, it was known to produce halogenated and non-halogenated depsidones which were reported to possess antibacterial, antifungal, brine shrimp larvacidal, enzyme inhibitory (AChE and aromatase), diphenyl-picryl hydrazyl (DPPH) free radical scavenging, and neuroprotective activities [17,18,19,20,21,22,23,24,25].
Because both strains are producers of antibiotics and neuroactive agents, it was appealing to investigate the effect of co-culture conditions on expression of their secondary metabolites, as this might result in the discovery of new antibiotics or anti-neurodegenerative agents. In this paper, we investigated the high-performance thin layer chromatographic (HPTLC) profiles, bioactivities, LC-MS/MS based GNPS molecular networking, and multiple natural product database mining of secondary metabolites deriving from co-culturing of these two marine fungi.

2. Results

2.1. Morphological Comparison

The two strains A. unguis and A. terreus were statically cultivated for a total of 28 days (in one stage or two stages) in seawater potato sucrose broth under 7 experimental condition groups, including: G1) A. unguis axenically for 28 days (abbreviated as axU); G2) A. terreus axenically for 28 days (axT); G3) A. unguis 7-day culture-inactivation + live A. terreus for the following 21 days (iacU-livT); G4) Live A. unguis 7-day culture + live A. terreus for the following 21 days (livU-livT); G5) live A. unguis and live A. terreus inoculated simultaneously (livU/livT) and co-cultivated for 28 days; G6) A. terreus 7-day culture-inactivation + live A. unguis for the following 21 days (iacT-livU); G7) Live A. terreus 7-day culture + live A. unguis for the following 21 days (livT-livU) (see details of the culture experiments in Section 4.2.1).
When A. unguis grows axenically, it initially forms scattered bright yellow colonies and then merges into a dark brown mycoderm (Figure 1G1). When A. terreus grows alone, it initially forms white colonies and then expands to form an off-white to brown mycoderm (Figure 1G2). If A. terreus is inoculated on the autoclaved 7-day culture of A. unguis, it still grows but just as small scattered off-white colonies on the dead mycoderm of A. terreus without forming its own continuous mycoderm (Figure 1G3). If A. terreus is inoculated on the live 7-day culture of A. unguis, no obvious growth of A. terreus is observed (Figure 1G4). When A. unguis and A. terreus are inoculated simultaneously, two types of mycoderms are observed: dark brown and off-white (Figure 1G5). When A. unguis is inoculated on the autoclaved 7-day culture of A. terreus, it does not grow as well as the axenic A. unguis culture but still forms its own complete mycoderm on the surface of the dead mycoderm of A. terreus (Figure 1G6). However, if A. unguis is inoculated on the live 7-day culture of A. terreus, the newcomers’ growth is not obvious (Figure 1G7). Comparing the different culture experiments, it was found that the early inoculated fungus (even if autoclaved) will inhibit the growth of the late inoculated one, and the live fungus showed stronger inhibition than the inactivated one.

2.2. Comparison of HPTLC Fingerprints

The profiles of secondary metabolites including their antioxidant as well as anti-AChE constituents were demonstrated using HPTLC images that were observed under 254 nm and 365 nm, colored by anisaldehyde reagent and potassium ferricyanide-ferric chloride (PFFC) reagent, and revealed by DPPH free radical scavenging and AChE inhibitory bioautographies, respectively. These HPTLC images revealed the variation between axenic cultures and co-cultures in different ways, including some dramatical changes.
The UV images (under 254 nm and 365 nm) clearly showed rich secondary metabolic profiles from the cultures. In the profile of axenic A. unguis (lane 1 in Figure 2A under 254 nm), the big dark spot with Rf value of 0.70 was judged to be comprised of depsidones according to our previous study on this strain [18]. For axenic A. terreus, the dark spot with Rf value of 0.28 was recognized from previous work as butyrolactone I [11]. These annotations were also supported by the LC-PDA-MS/MS analysis as described below in Section 2.4.
In the experiment G3 (iacU-livT), some A. terreus metabolites disappeared including the spots at Rf 0.43 (orange fluorescence), Rf 0.38 (red fluorescence), and Rf 0.17–0.30 (dark blue, including butyrolactone I). However, other putative A. terreus metabolites were enhanced in their production, including white fluorescent spots at Rf 0.84 and Rf 0.68. Moreover, several new constituents appeared in this co-culture including fluorescent spots at Rf 0.76 (light orange), Rf 0.58 (white), and Rf 0.20 (white) as marked with the yellow arrows (Figure 2B under 365 nm). Remarkably, the typical A. unguis depsidone metabolites still appeared in this co-culture (Figure 2A under 254 nm), indicating their thermostability against autoclaving.
In the experiment G4 (livU-livT, inoculated in tandem), the UV images were basically the same as those of the axenic A. unguis, indicating that the later inoculated A. terreus was extremely suppressed in its growth and production of metabolites. This is consistent with the morphological observation described above.
In experiment G5 (livU/livT, inoculated simultaneously), the UV images greatly differed from those of G3 and G4, but closely resembled those of G2 (the axenic A. terreus). However, some A. terreus products were produced in lower yields such as the spot with Rf 0.38 (red fluorescence), or even vanished such as the one with Rf 0.43 (orange fluorescence). In contrast, some spots, like the white fluorescent spots with Rf 0.84, 0.67, 0.32, and 0.08, were significantly enhanced to a much higher extent than in co-culture G3. As for A. unguis metabolites, only a small quantity of depsidone metabolites (Rf 0.67) was observed under 254 nm. This situation agreed with the growth advantage of A. terreus vs. A. unguis in Figure 1G5.
In the experiment G6 (iacT-livU), the UV image under 365 nm was similar to that of axenic A. terreus, suggesting that the A. terreus metabolites were quite thermotolerant against autoclaving and were stable over a three-week period. The depsidones of A. unguis were present but with much lower yield compared to the axenic A. unguis culture. Therefore, even the autoclaved A. terreus can remarkably inhibit the growth or metabolism of A. unguis.
Likewise, in experiment G7 (livT-livU, inoculated in tandem), the UV image displayed almost identical features with the axenic A. terreus cultures; however, the depsidones from A. unguis could barely be observed.
The results of anisaldehyde and PFFC colorization (Figure 2C,D) were consistent with the UV findings. Additionally, they revealed the production of new metabolite during the co-cultivation experiments. For example, the following were new compounds: blue gray spot at Rf 0.58 in experiment G3, gray spot at Rf 0.82 in G4 (both with anisaldehyde detection), brown spot at Rf 0.27 and brownish spot at Rf 0.40 (both with PFFC detection).
The two bioautographies revealed the antioxidant and anti-AChE constituents in the different culture experiments (Figure 2E,F). The depsidones showed antioxidant and anti-AChE activities, while butyrolactone I showed antioxidant activity. Their variation in amounts (Figure 2A) were partially reflected in the changes of the bioactive spots in these bioautography experiments. Nevertheless, some minute new anti-AChE spots (Rf 0.32 and 0.36) were also observed in co-culture G3, and differences in highly polar constituents remaining at the point of application cannot be excluded because the mobile phase (chloroform:methanol = 20:1 (v/v)) was not polar enough to mobilize them in the chromatogram.
Generally, the HPTLC suggested the following trends: (1) the strain firstly inoculated will strongly inhibit the growth and metabolism of the later inoculated one, (2) the autoclaved A. unguis exerted a strong inducing effect on the later inoculated A. terreus, while the autoclaved A. terreus showed high stability of its metabolites and still potently suppressed the growth and metabolism of A. unguis, (3) when the two strain were inoculated simultaneously, they both grew and produced metabolites. However, the A. terreus seemed to be more strongly induced by live A. unguis and this inducing effect surpassed that of the autoclaved A. unguis. Finally, A. unguis was negative in response and agonism but potent in stimulating its rival while A. terreus had the opposite effect.

2.3. Antimicrobial Activity

Based on the above preliminary co-cultural product HPTLC analysis, the antimicrobial activities of the extracts were further tested against several indicator strains, including Methicillin-resistant Staphylococcus aureus (MRSA), Bacillus subtilis, Pseudomonas aeruginosa, Vibro parahemolyticus, V. alginolyticus, Shewanella putrefaciens, Yersinia pseudotuberculosis, and Candida albicans. The results are shown in Table 1 and the representative photos below in Figure 3.
In these experiments, axenic A. unguis extracts exhibited much stronger broad-spectrum antimicrobial activity against the selected indicator strains than axenic A. terreus extracts. However, as revealed by morphological evaluation and HPTLC fingerprints, the A. terreus possessed strong inhibition against A. unguis, even by its autoclaved medium. This antifungal activity, though, may be specific to A. unguis, since C. albicans showed low sensitivity to the axenic A. terreus products.
When A. unguis grew well and fully, such as in the livU-livT (G4) experiment, the overall activity of the co-culture reached comparable levels of axU (G1). However, it was noticed that its activities against B. subtilis and P. aeruginosa were remarkably higher than those of axU (G1), which was possibly related to the higher depsidone metabolites yield under this condition as shown by HPTLC.
While A. unguis was inactivated by autoclaving after the first week or grew weakly when co-inoculated or late inoculated, with low yields of depsidones, the antimicrobial spectra and the inhibition potency of the co-cultural products would be generally weakened, as depicted in the results of iacU-livT(G3), livU/livT(G5), iacT-livU(G6), and livT-livU(G7). Nevertheless, the anti-B. subtilis and anti-S. putrefaciens activities of livU/livT(G5) were enhanced by co-culture, and the anti-C. albican activity of iacU-livT(G3) also became higher than axU (G1), suggesting that new antimicrobial substances may be produced in co-cultures. Taking into account, too, the remarkable increase in total extract amounts, the extent of the activity enhancement is even more dramatic because the activities reported in Table 1 are the results from identical sample concentrations. Considering that the strong inducing effect of A. unguis towards A. terreus and the antifungal potential of A. terreus (against A. unguis in co-cultures), the antifungal activity of iacU-livT(G3) was possibly from the induced products of A. terreus.

2.4. Metabolits Profile Comparison by LC-PDA-MS/MS and Multiple Database Mining

To further investigate the metabolic profile variation occurring as a result of co-cultivation, and to annotate putative antimicrobial compounds and their derivatives, LC-PDA-MS/MS analysis and GNPS molecular network-based analyses were performed for the extracts of the seven experimental setups. As a supplement to GNPS automatic metabolite annotation, manual searching was also performed to find possible candidates for the compounds showing dramatic changes in yield. This latter analysis used several open accessible natural product databases including PubChem, Dictionary of Natural Products (DNP), NPASS, Natural Product Atlas, and Nmrdata (WeiPu). The deduced molecular weights, isotopic patterns (for chlorinated metabolites), UV features, and taxon information (mainly within the Genus of Aspergillus and expanded to the kingdom of fungi when necessary) were queried in these database searches.
In general, the LC-UV profiles (under 280 and 360–370 nm) together with the LC-MS BPC profiles (under both positive and negative MS modes) (Figure 4, Figure 5, Figure 6 and Figure 7) show the similar trends in fungal metabolite production in co-cultures as those observed by HPTLC. Especially, the 360–370 nm UV monitoring (although without fluorescent detection) showed rich upregulated peaks from A. terreus (G5 vs. G3) as displayed by the fluorescent components in HPTLC results but not by MS monitoring. These observations suggest that live A. unguis had a stronger inducing ability to A. terreus than the autoclaved one. These results also suggestion that the fluorescent substances may be not readily ionizable, or that they are present in very low quantity.
Totally, 15 MS detectable main peaks were chosen based on their significant variation in yield compared with the corresponding axenic cultures (Table 2) and submitted to annotation by GNPS and the multiple database mining approach described above. Their complete information is summarized in Table 3; the peaks are marked in Figure 4, Figure 5, Figure 6 and Figure 7 and the selected annotated structures are presented in Figure 8 and partially by GNPS in Figure 9 and Figure 10. By comparison of the axenic and co-culture LC profiles, peaks 1, 2, and 5–13 were assigned to be A. terreus metabolites, and peaks 2–4, 14, and 15 were assigned to A. unguis metabolites. Specially, peak 2 was produced by both strains.
Compared with the axenic A. terreus, most of its metabolites except peak 2 were remarkably decreased in yield when A. terreus was inoculated one week after A. unguis (i.e., groups G3: iacU-livT and G4: livU-livT). Moreover, live A. unguis showed a stronger suppressive effect than the autoclaved material, indicating the inhibition of A. unguis metabolites towards A. terreus (Table 2).
Peak 7 was annotated to be the typical A. terreus metabolite lovastatin by MS/MS similarity to GNPS records. Its UV features showed a difference to related literature values [15,16] which was possibly caused by unknown impurities in the peak. Peak 8 appeared in the same cluster in the GNPS molecular network (the node with average m/z 427.256 for peak 7 and the node with average m/z 459.273 for peak 8 in Figure 9A) and was therefore also proposed to be a statins. Peaks 7 and 8 were dramatically upregulated in G5 and G7 (when A. terreus was inoculated simultaneously with or prior to A. unguis, respectively), indicating that they were employed in antagonistic responses to A. unguis. This phenomenon is also consistent with the antifungal activity reported for statin natural products [26,27]. In G6 (iacT-livU), these two compounds remained in high concentration even though the 1-week A. terreus culture was autoclaved, indicating that they were produced in the early stage of growth and possessed good stability to persist in their inhibition to A. unguis. This was indicated by the weakened mycelial growth and downregulated metabolites observed in HPTLC and LC profiles of group G6 A. unguis.
Four peaks (1, 5, 10, and 11) all increased in G7 (livT-livU) but were reduced in the simultaneously inoculated G5 experiment (livT/livU). Among them, peaks 5 and 11 were also increased in group G6 (iacT-livU) but to a lesser extent than G7, but peaks 1 and 10 were decreased in G6. Their varied production levels suggest that all four compounds may contribute to the competitive success of pre-inoculated A. terreus growth in co-cultures; however, their potency may be too low to be effective in the spontaneous inoculation co-culture G5. Peaks 5 and 11 were deduced to be produced in the early stage of growth and stable, whereas peaks 1 and 10 may be not stable or are synthesized late in the growth cycle. Although GNPS did not provide any annotations for these latter metabolites, query of multiple databases provided some clues as to their identities. For peak 1 there was 1 hit, a diketopiperazine with end absorption similar to what was observed. There were 3 possible hits (anthraquinones aspergilols A, B, and G) for peak 5 which included UV absorptions most similar to aspergilol G [28]; however, only by UV comparison, aspergilols A and B cannot be definitely excluded since they were also reported to have similar UV absorptions to peak 5. Two hits were found for peak 10 with similar UV profiles as the cyclopeptide epichloenin A and diketopiperazine-aluminum salt astalluminoxid (the former with reported antifungal activity) [29,30]. Peak 11 has a similar molecular weight to the antifungal Tyr-containing cyclic peptide KK-1 from the database Natural Product Atlas (record NPA028479), but their distinct UV properties rule out the possibility of such a match. [31].
Another four peaks (6, 9, 12, and 13) were all downregulated in experimental groups G5, G6, and G7. Peak 9 was nearly eliminated in all the groups, indicating that it may be not important to this fungal strains’ arsenal of allelochemicals. The down regulation of these four compounds is consistent with their not being involved in the antagonistic behavior of this fungus, and is consistent with economizing unused metabolic pathways during stress conditions. GNPS and database mining gave reliable annotations for peak 6 as the known AChE inhibitor territrem B [15,32,33] and for related peak 9 the antibacterial sesterterpene terretonin G. The latter annotation had similar UV characteristics [34]. For peak 12, five compounds with similar molecular weights and high polarity were found, i.e., Aspergillussanone H, Nigerasperone B, Aurasperone B, and Fumigatosides C-D from Aspergillus spp. [35,36,37,38,39,40], but their rich UV absorptive peaks ruled them out since peak 12 essentially only showed end absorption. Nevertheless, two possibilities, austamide (diketopiperizine) and asperimide A (containing a maleimide ring), had the most similar UV spectra to peak 13 out of the 3 hits [41,42]. Likewise, most of the A. unguis metabolites (peaks 3, 4, and 15) all were reduced in groups G6 and G7 when A. unguis was inoculated 1 week afterwards, reflecting the inhibition of A. terreus metabolites to A. unguis (Table 2). However, these three compounds changed in quite different ways in experimental groups G3, G4, and G5. For instance, peak 3 was produced in substantially higher yields in G5 (livU/livT, spontaneous inoculation) and G4 (livU-livT, A. unguis inoculated first) in contrast to its very low production level in G3 (iacU-livT). These results suggest that it was probably produced by A. unguis to oppose A. terreus and it was possibly a non-thermostable metabolite synthesized in its early growth stage. GNPS analysis along with a query of multiple databases did not provide a reasonable annotation based on molecular weight (776 Da), (MS2 features), and UV (end absorption) (Table 3).
Peak 4 was annotated as the cyclopeptide unguisin A by combining the multiple database mining [43], our previous work on this strain [17], and manual interpretation of its MS/MS spectrum (Figure 11). This compound was increased by more than 3 folds in A. unguis first inoculated groups G4 (livU-livT) and G3 (iacU-livT), whereas it was moderately downregulated in G5 (livU/livT). This profile suggests that it was useful in maintaining the predominance of A. unguis in co-culture, but is not likely a major component of its antagonistic arsenal.
Peak 15 showed a typical isotopic pattern for a tri-chlorinated compound by mass spectrometry (Table 3 and Figure S20), and was thus annotated as nidulin based on GNPS matching, multiple database mining [23], and our previous studies [17,18]. Its production in groups G3 (iacU-livT), G4 (livU-livT), and G5 (livU/livT) was reduced to different extents but not eliminated. In co-cultures G4 and G5 with live A. unguis, its yield still reached about 50% of the level observed in G1, suggesting that it played a positive yet minor role in this antagonistic response.
Noteworthily, peak 14 had an isotopic cluster typical of a dichlorinated metabolite (Table 3 and Figure S19) with four dichlorinated but UV distinct ‘hits’ in the kingdom of fungi, but no hits from the genus Aspergillus by GNPS matching or query of multiple databases [44,45]. Interestingly, it was not detected in monocultures of A. unguis and A. terreus. However, considering the observed halogenation ability of A. unguis [17,18,46], it is likely a metabolite of this latter fungus. It is intriguing that it was not produced in monoculture nor in G4 when it had the advantage of earlier inoculation, but only when the two strains were inoculated at the same time. As the competition was more intense as in G7 (livT-liv U) and A. terreus preemptively produced inhibitory factors as in G6 (iacT-liv U), its production was increased. This profile suggests that it might be a metabolite that provides resistance to the stress imposed by A. terreus metabolites. Furthermore, it is interesting that autoclaved A. terreus had a much stronger ability to induce production of peak 14 than live cultures, inferring that some potent and thermostable inducers are produced in the early stage of A. terreus growth.
Peak 2 is able to be produced by both Aspergillus species; however, the yield in A. terreus was about triple that of A. unguis; and under different co-culture conditions, its yields were higher than the monocultures; but it was not possible to discern which strain contributed more under the co-culture conditions. GNPS and multiple database mining did not give a clear indication of its identity with only one hit suggested, an anti-melanogenic triterpenoid saponin from Aspergillus. It had an identical molecular weight and end UV absorption [47]; however, more studies are necessary to confirm its identity and function as a potential allelochemical.
Briefly, the variation in features in different co-culture experiments revealed that both strains have allelochemicals that are produced in antagonistic conditions. Some metabolites appear to be involved in maintaining the predominance of first inoculated strain, others may be involved in anti-stress responses, and still others are down regulated in these conditions, presumably because they are not involved in these competitive interactions.
In addition to these 15 peaks observed in the LC-MS profiles, GNPS also annotated several other metabolites by MS/MS similarity comparisons as shown in Figure 9 and Figure 10. Some of these also varied in production levels in the different culture experiments, such as a siderophore-like desferrioxamine with m/z 478.228 together with its congener showing up in axenic A. terreus (G2) and other cultures in cluster F. Additionally, an open-ring di-chlorinated depsidone with m/z value 426.979 was produced in extremely low yield (Figure 10). However, classical GNPS networking can potentially sum the intensity of ions into the same node that possess ‘identical’ m/z values and MS/MS profiles but quite different retention times (e.g., isomers). Therefore, this quantification is not as reliable as EIC integration of the original LC-MS profiles.

3. Discussion

Based on the comparison of monocultures (axenic cultures) and co-cultures in different configurations for their mycelial morphology, HPTLC-bioautography analysis of secondary metabolic profiles, antimicrobial tests, and LC-PDA-MS/MS analysis, the first inoculated Aspergillus strains were commonly observed to predominate in co-cultures. This was true even when the culture was autoclaved one week into the experiment, as it still suppressed the growth and production of metabolites in the latter inoculated strain. When both strains of Aspergillus were inoculated simultaneously, they each grew in reasonable yield and produced their secondary metabolites (SMs). When A. terreus was inoculated before A. unguis, it produced its characteristic metabolites, including statins, undetermined peaks (e.g., 1, 5, 11), and desferrioxamines. Similarly, when A. unguis was first inoculated in the co-culture, it produced its typical metabolites, including unguisin A, nidulin, and undetermined peak 3. Meanwhile, the strains dramatically downregulated several metabolites that possessed no or only weak antimicrobial activity, and therefore, these latter compounds seem unrelated to the antagonistic phenotype of each fungus. This was especially the case when they were the latter inoculated strain in the co-cultural experiment. Nevertheless, A. unguis produced new dichlorinated metabolites only when it was extremely stressed by the simultaneous or second in the sequence inoculation, but not when it grew alone or was inoculated prior to A. terreus. On the other hand, A. terreus was induced to synthesize unknown compounds that did not ionize well in MS, but had strong white fluorescence on TLC analysis. This was especially the situation when simultaneously inoculated with A. unguis, which may be responsible for the enhanced antibacterial activity of extract of G5. In this case, the known antimicrobial agent nidulin was downregulated by A. unguis in this co-culture condition. Given this profile of expression, these unknown compounds may have anti-stress activities in the two Aspergillus strains. The overall results suggest that A. unguis was relatively ineffective in mounting an agonistic phenotype in culture, but was quite potent in stimulating its rival A. terreus to mount a strong response. The opposite was true for A. terreus in that it produced strongly antagonistic natural products but elicited little response from the competing fungus A. unguis.
Previous studies have revealed that co-cultivated microbes, such as fungi, often secrete extracellular diffusible SMs like phenols and quinones as well as enzymes such as phenoloxidases, peroxidases, and lignin-degrading enzymes, to suppress rivals or compete for new resources [48]. These competitive interactions occur even between different intraspecies strains; for example, the non-aflatoxigenic Aspergillus flavus can inhibit the aflatoxigenic A. flavus via antifungal SMs and antioxidants [49]. Numerous induced microbial SMs are involved in microbial antagonism as manifested by the fact that 37% have been reported with antibacterial, 7% with antifungal, and 35% with cytotoxic activities, together with 9% having other related activities including 3% as siderophores, 2% as α-glucosidase inhibitors, 1% as ATP synthesis inhibitors, and 3% as pesticides [50]. It has also been reported that the first inoculated strain in co-culture experiments usually predominates in the production of SMs, and that their yields can be even higher than in the corresponding mono-culture conditions. This concept was demonstrated by the co-cultivation of Streptomyces rimosus and A. terreus in a stirred tank bioreactor [51], and is reinforced by the findings of this present study.
Co-culture has increasingly been recognized as an efficient approach to activate silent biosynthetic gene clusters (BGC). This has been partially attributed to chromatin remodeling via epigenetic modifications [50,52]. For example, intimate physical contact of Streptomyces rapamycinicus to hyphae of Aspergillus nidulans has been shown to trigger the latter’s multi-subunit transcriptional co-activator complex SAGA/ADA, which in turns leads to histone H3K9 acetylation of transcription factor basR and ors BGC and the final production of SMs such as orsellinic acid [52,53]. Similar mechanisms are also known to occur in fungus-fungus co-cultures. The up-regulation of O-methylmellein was observed in the co-culture of two plant pathogens, Eutypa lata and Botryosphaeria obtuse. Interestingly, its production was also upregulated in the fungus Stagonospora nodorum by application of the epigenetic modifiers SAHA and nicotinamide [48,54,55]. Moreover, in a previous study by our group, a higher yield of unguisin A was observed in a A. unguis monoculture supplemented with both chemical epigenetic modifier procaine chloride and NaBr [17]. This previous finding is consistent with its significantly higher yields in the co-culture experiments G3 and G4 with A. terreus, and suggests that regulation of production of unguisin A may involve epigenetic mechanisms.
A literature-based search of MS-based features encountered in this study further supported their potential chemecological roles in these co-culture experiments. For example, unguisin A was initially reported from marine fungus Emericella unguis (the teleomorph of A. unguis); and while our previous investigations as well as a series of other studies did not detect potent antibacterial or antifungal activity for unguisin A [17,43,56], it was reported to be a promiscuous binder to various anions with particularly high affinity for phosphate and pyrophosphate [56]. Phosphorus is critical to fundamental life processes, and competition for phosphate is known to exist in microalgae-bacteria and microalgae-microalgae co-culture systems. Moreover, arbuscular mycorrhizal fungi have an important role in phosphorus absorption for their plant hosts [57,58,59]. Therefore, it is reasonable that in the A. unguis-A. terreus co-culture system of this present study, unguisin A may help A. unguis to acquire more phosphate and thus maintain its predominance over A. terreus when it is the first inoculated strain. It was surprising that in the G3 experiment (iacU-livT), this compound was maintained at high levels; this may be attributed to its relatively good stability. Additionally, it is conceivable A. terreus may use this A. unguis-derived compound to enhance its phosphate assimilation, as ’borrowing’ SMs from rival microbes is not uncommon [60].
Statin molecules such as lovastatin and simvastatin are typical A. terreus metabolites. They are used as lipid lowering drugs by inhibiting HMG-CoA in cholesterol biosynthesis, and have been shown to inhibit the growth of various Aspergillus spp. (A. fumigatus, A. flavus, A.niger, A. terreus, etc.) and yeasts like Candida albicans. This growth inhibition occurs via multiple mechanisms, including HMG-CoA inhibition, iron starvation, induction of DNA fragmentation, fungal cell morphogenesis disruption, and others [27,61,62]. Variation in the production levels of statins was also investigated when A. terreus was co-cultivated with Penicillium rubens, Chaetomium globosum, and Mucor racemosus, respectively [63,64]. These experiments showed that the yields of lovastatin and its derivatives did not increase or were even lower than the yields in A. terreus monoculture, due partially to transformation into monacolin J. Nevertheless, in the present study the yields of lovastatin and its analog peak 8 were significantly larger compared to the monoculture; this may have been caused by the strong inducing effect of A. unguis towards A. terreus.
Halogenated compounds are an important class of marine fungal natural products (NPs). In 1994–2019, a total of 217 halogenated compounds were discovered from marine fungi, among which 88% were chlorinated compounds. Moreover, 18.9% were reported with antimicrobial activities, 35 were from the genus Aspergillus including 4 from A. unguis (all as depsidones), and none from A. terreus [65]. The PubChem database mainly records natural products from two original databases, the Natural Product Atlas (NPA) and the Natural Product Occurrence Database (NPOD). Duplicate records occurring in both databases are not excluded. Our search of PubChem returned 141 (from NPA) and 377 (from NPOD) A. terreus natural products, with 12 chlorinated ones (3 from NPA and 9 from NPOD) (total proportion 2.3%). From A. unguis we found that there were 19 NPs from NPA plus 58 NPs from NPOD with totally 24 (3 from NPA and 21 from NPOD) chlorinated ones (total proportion 31.2%). These data indicate that A. unguis possesses a much higher potential for producing chlorinated NPs than A. terreus. The tri-chlorinated NP nidulin that was found in this study is also known from A. unguis and A. nidulans, and has been characterized to possess antibacterial and moderate antifungal activities [17,18,64,65,66,67,68]. In co-cultural experiments G3-G6 in this study, the yield of nidulin was reduced although it remained at considerable levels of 14% to 56% of the yield from monocultures. We noticed that the extracts (1 mg/mL) of all the groups containing A. unguis that were growing well, such as axU (G1), showed comparable antimicrobial activity to the positive control ampicillin (0.1 mg/mL). This potent activity was possibly derived from nidulin, the main metabolite of A. unguis, and may also come from synergetic effects from other components. Furthermore, in experiments G5–G7, an unknown dichlorinated metabolite was upregulated under stress conditions. These results suggest that chlorinated NPs have chemical defensive functions in this fungus.
Siderophores are unique molecules that various organisms have evolved for the capture and assimilation of iron that is necessary for live. As such, they are intimately involved in iron resource competition during microbial co-cultures [51]. Hydroxamines (also as desferrioxamines, DFOs) are the most common siderophore family in nature and the main siderophore type produced by fungi. Fungi of the genus of Aspergillus are reported to produce DFOs consisting of ferrichromes and linear/cyclic fusarines [69,70]. The node with m/z value of 478.228 (Figure 9) was annotated by GNPS as a linear fusarine, although being different from any of the known Aspergillus fusarines. GNPS networking revealed that in the two monocultures, it was only produced by A. terreus. It was also present in the co-culture experiments G3, G5, and G7 where the live A. terreus was relatively easy to grow. These results are consistent with the use of this fusarine analog by A. terreus for iron uptake. These features along with the others discussed above may play important roles in the co-culture system.
In this current study, MS2-based molecular networking was employed based on data from an ion trap MS/MS instrument operating at low mass resolution. Using the GNPS platform, the combination of MS1 and MS2 data provided good putative annotations for metabolites observed in these co-culture experiments. However, for compounds unmatched by the GNPS analysis, a tedious manual searching across multiple NP databases was performed using likely molecular weights, taxonomical information, and UV spectral features. Nevertheless, solid verification of annotated or unknown metabolites requires confirmation by scaled-up fermentation, isolation, and structural elucidation by comprehensive spectroscopic methods. This confirmatory work is necessary and common to all mass spectrometry-based metabolomics studies, and is made especially challenging in co-culture studies which are inherently more difficult to reproducibly control.
In the current study, predominance of one fungus over the other in these co-culture experiments mainly relied on macroscopic morphological observations and comparisons of metabolite yields, neither of which method is direct or completely accurate. In future studies, microscopic observation, real-time quantitative PCR, microbiota amplifier high-throughput sequencing for ITS rDNA or metagenome sequencing, or transcriptomics approaches could be used to understand variations in the fungal community and gene expression more fully and accurately.
In summary, this study is the first report on the co-culture between Aspergillus terreus and A. unguis and reveals that A. terreus is more aggressive and responds to its rival’s presence, while A. unguis is less robust in its response but potent in stimulating its rival’s allelochemicals. It reveals their tendency to maintain dominance by synthesizing secondary metabolites and discloses the production of an unknown dichlorinated compound by A. unguis and strongly fluorescent products by A. terreus under stress. These results provide a deeper understanding of fungal co-culture mechanisms as well as the discovery of new natural products. This study also revealed a couple of shortcomings in the use of GNPS for compound annotation. The limited number of library records impacts the extent of automatic matching that can be achieved by GNPS. Additionally, an automatic analysis of isotopic peak clusters for recognizing the occurrence of halogenated compounds is current lacking. These aspects make necessary a complementary manual analysis of the data as well as querying of multiple databases via spectral features and taxonomic information.

4. Materials and Methods

4.1. Materials

The marine fungus A. terreus C23-3 was collected from the Xuwen Coral Reserve in Zhanjiang and is now preserved in the Guangdong Provincial Microbial Culture Collection, with the deposit number GDMCC No. 60316. The marine fungus A. unguis DLEP2008001 was derived from a red alga from the seaside of Fujiazhuang, Dalian, Liaoning Province, China and deposited in China General Microbiological Culture Collection Center with number CGMCC 3372. Bacillus subtilis MCCC 1A03710 was purchased from China Marine Microbial Culture Collection; Pseudomonas aeruginosa and Candida albicans, were from American Typical Culture Collection with numbers ATCC 9027 and ATCC 10231, respectively; Vibrio parahaemolyticus was donated by Professor Wen Chongqing, Fisheries College, Guangdong Ocean University; V. alginolyticus and Shewanella putrefaciens were presented by Professor Liu Ying from the School of Food Science and Technology, Guangdong Ocean University; Methicillin-resistant Staphylococcus aureus A7983 was gifted by Professor Yu Zhijun from Dalian Friendship Hospital. The acetylcholinesterase (AChE, from electric eels) and DPPH were purchased from Sigma-Aldrich (St. Louis, MO, USA). All the organic mobile phase solvents for LC-MS were from Merck (Darmstadt, Germany). All the other reagents were with analytical purity.

4.2. Methods

4.2.1. Co-cultivation and Extraction of Strains

The strain A. terreus C23-3 and A. unguis DLEP2008001 were activated at 28 °C overnight and then inoculated, respectively, into conical culture flasks pre-filled with 200 mL of sterilized seawater potato solid medium for cultivation for 3-4 days until rich spores grew on the colonies. Then spore suspensions were prepared as seeds by washing the spores with sterile saline. Afterwards, the seed suspensions were inoculated into 500 mL Erlenmeyer flask each filled with 100 mL seawater potato sucrose liquid medium (containing 20 g sea salt, 20 g sucrose, and 500 mL potato juice per liter) according to the following group design. Each group contained three replicates.
Experiment grouping:
G1:
A. unguis cultivated separately for 4 weeks (axenic A. unguis, abbreviated as axU);
G2:
A. terreus cultured separately for 4 weeks (axenic A. terreus, abbreviated as axT);
G3:
Inactivated A. unguis + live A. terreus (abbreviated as iacU-livT. In detail, A. unguis was inoculated first, cultured for one week and then iactivated by autoclaving; Afterwards, A. terreus was inoculated into the same flask and cultured for the next three weeks);
G4:
Live A. unguis + live A. terreus (abbreviated as livU-livT; Similar to G3, but the first inoculated A. unguis was not autoclaved);
G5:
Live A. unguis/Live A. terreus (abbreviated as livU/livT; The two strains were simultaneously inoculated into the same flask and cultivated for 4 weeks);
G6:
Inactivated A. terreus + live A. unguis (abbreviated as iacT/livU; Similar to G3, but the inoculation order was opposite);
G7:
Live A. terreus + A. unguis (abbreviated as livT-livU; Similar to G4, but the inoculation order was opposite).
During the 4-week cultivation, daily observation and photography were made to record the morphology of the cultures. After the four weeks, the fermentation broth was extracted three times with equal volumes of ethyl acetate. The mycelium was extracted three times with methanol assisted by ultrasonication; then the two extracts were concentrated, combined, and evaporated to dryness, weighed, and kept at 4 °C for further use.

4.2.2. Thin Layer Chromatography (TLC) Analysis and Bioautography

All samples were prepared as methanol solution with concentration of 10 mg/mL of TLC analysis. The mobile phase was chloroform: methanol (volume ratio 20:1), the solid phase was Silica gel 60 F254 plate produced by Merck, and the volume was 10 μL. The plates were observed under 254 and 365 nm UV lights, stained by anisaldehyde-sulfuric acid reagent and potassium ferricyanide-ferric chloride (PFFC) reagent, respectively, or displayed for bioactive spots by DPPH free radical scavenging and AChE inhibitory bioautographies [71]. All the parallel samples were preliminarily checked for repeatability by TLC before formal experiments. All experimental results were recorded by photography.

4.2.3. Antimicrobial Assay

The screening was performed using the bilayer agar plate-Oxford cup method [72,73]. The upper agar (5 mL) containing 0.5 mL of bacterial suspension with a concentration of 1 × 108 CFU/mL. h = The Oxford cups (with inner diameter of 6 mm and outer diameter of 8 mm) were filled with 200 μL of sample (concentration = 1 mg/mL). The plates were incubated at 37 °C for 16–18 h. The results were expressed in average diameters of inhibition zones and standard deviations. The standard Muller–Hinton agar and Sabouraud agar were used for antibacterial and antifungal test, respectively (the medium of Vibrio parahaemolyticus contains 1% sodium chloride).

4.2.4. LC-MS/MS Analysis

The nominal mass resolution LC–MS/MS analyses were run on a Thermo Finnigan LC-PDA-MS/MS system equipped with PDA Plus detector and a LCQ Advantage Plus ion-trap mass spectrometer (ThermoFinnigan, San Jose, CA, USA).
All the extract samples were prepared as methanol solutions in which the dryness contents were in proportion to the total crude extract amounts for each culture by weighting, dissolving with LC-MS pure methanol, and pretreating with Agilent SPE column. The DAD detector signal collection wavelength was 190–600 nm, and the monitoring wavelength was 210 nm, 254 nm, and 280 nm. The chromatographic column is a Phenomenex Kinetex C18 100A reverse-phase chromatographic column (100 × 4.60 mm, 5 μm). The detail of the mobile phase is listed in Table 4.
Mass spectrometry detection conditions: the mass scan range set to m/z 100–2000 Da, electrospray ionization; ion source: ion source voltage: 4 kV, capillary temperature: 325 °C, normalized collision energy: 35 eV, ion transfer tube voltage: 10 V. Trigger signal intensity threshold of the secondary mass spectrum: 1 × 105 CPS (Count Per Second) for positive ion mode, and 1 × 104 CPS for negative ion mode.

4.2.5. GNPS Molecular Network Analysis

Standard pipeline for GNPS molecular networking was performed by referring to the previous reports [6,70]. The parameters for clustering and compound matching were set as: minimal matching fragments to be 4; minimal cluster size to be 2; cosine threshold to be 0.7; searching database scope to be the whole GNPS library. The data visualization is carried out with Cytoscape 3.7.2 software.

4.2.6. Multiple Natural Product Databases Mining

The multiple natural product databases mining were performed on several open accessible online databases including the PubChem (https://pubchem.ncbi.nlm.nih.gov/#, 19 January 2022), the Dictionary of Natural Products (DNP) (http://dnp.chemnetbase.com/, 19 January 2022), the NPASS (http://bidd.group/NPASS/, 19 January 2022), the Natural Product Atlas (https://www.npatlas.org/, 19 January 2022), and the Nmrdata (WeiPu) (http://www.nmrdata.com/, 19 January 2022) using deduced molecular weights with error range of targeted MW ± 1 Da (or 2 Da for chlorinated metabolites), isotopic pattern (for chlorinated metabolites), UV features, and taxon information (mainly within the genus of Aspergillus and expanded to the kingdom of fungi when necessary).

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antibiotics11040513/s1, Table S1. The integrated areas for the differential compounds in co-cultures compared to the axenic cultures in extracted ion chromatographies. Figures S1–S20. The MS and MS/MS spectra of featured peaks under positive or negative mode. Table S2. Multiple database mining for the peaks without remarkable yield changes in LC-MS traces between axenic and co-cultures while annotated by GNPS matching.

Author Contributions

Conceptualization, Y.Z.; Funding acquisition, Y.Z. and P.H.; Investigation, Y.W., Y.Z., E.G., Y.H., Y.L., L.Z., X.M. and X.H.; Writing—first draft by Y.W., final draft by Y.Z., review & editing by W.H.G., E.G., Y.Z., Y.L., L.Z. and Y.H. All authors have read and agreed to the published version of the manuscript.

Funding

Special project in key fields of Guangdong provincial higher education institutions (Biomedicine and health care)(2021ZDZX2064); Guangdong Provincial Special Project in Science and Technology (2021A50114); the Yangfan Talent Project of Guangdong Province (201433009); the Basic Research Project of Shenzhen Science and Technology Innovation Commission (JCYJ20190813105005619); Shenzhen Dapeng New District Scientific and Technological Research and Development Fund (KJYF202001-07); the Innovation and Development Project about Marine Economy Demonstration of Zhanjiang City (Zhan-Hai-Chuang XM-202008-01B1); the Innovative Team Program of High Education of Guangdong Province (2021KCXTD021).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311–335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Mayer, A.M.S.; Guerrero, A.J.; Rodriguez, A.D.; Taglialatela-Scafati, O.; Nakamura, F.; Fusetani, N. Marine pharmacology in 2016–2017: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar. Drugs 2021, 19, 49. [Google Scholar] [CrossRef] [PubMed]
  3. Marmann, A.; Aly, A.H.; Lin, W.H.; Wang, B.G.; Proksch, P. Co-cultivation—A powerful emerging tool for enhancing the chemical diversity of microorganisms. Mar. Drugs. 2014, 12, 1043–1065. [Google Scholar] [CrossRef] [Green Version]
  4. Williams, R.B.; Henrikson, J.C.; Hoover, A.R.; Lee, A.E.; Cichewicz, R.H. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem. 2008, 6, 1895–1897. [Google Scholar] [CrossRef]
  5. Peng, X.Y.; Wu, J.T.; Shao, C.L.; Li, Z.Y.; Chen, M.; Wang, C.Y. Co-culture: Stimulate the metabolic potential and explore the molecular diversity of natural products from microorganisms. Mar. Life Sci. Technol. 2020, 3, 363–374. [Google Scholar] [CrossRef]
  6. Rateb, M.E.; Hallyburton, I.; Houssen, W.E.; Bull, A.T.; Goodfellow, M.; Santhanam, R. Induction of diverse secondary metabolites in Aspergillus fumigatus by microbial co-culture. RSC Adv. 2013, 3, 14444–14450. [Google Scholar] [CrossRef] [Green Version]
  7. Wang, M.X.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef] [Green Version]
  8. Oppong-Danquah, E.; Parrot, D.; Blumel, M.; Labes, A.; Tasdemir, D. Molecular networking-based metabolome and bioactivity analyses of marine-adapted fungi co-cultivated with phytopathogens. Front. Microbiol. 2018, 9, 2072–2108. [Google Scholar] [CrossRef]
  9. Ibrahim, S.R.M.; Mohamed, G.A.; Khedr, A.I.M. γ-Butyrolactones from Aspergillus species: Structures, biosynthesis, and biological activities. Nat. Prod. Commun. 2017, 12, 791–800. [Google Scholar] [CrossRef] [Green Version]
  10. Chen, S.W.; Zhang, Y.; Niu, X.T.; Mohyuddin, S.G.; Wen, J.; Bao, M.L.; Yu, T.Y.; Wu, L.Y.; Hu, C.Y.; Yong, Y.H.; et al. Coral-derived endophytic fungal product, butyrolactone-I, alleviates LPS induced intestinal epithelial cell inflammatory response through TLR4/NF-κB and MAPK signaling pathways: An in vitro and in vivo studies. Front. Nutr. 2021, 8, 748118. [Google Scholar] [CrossRef]
  11. Zhang, Y.Y.; Zhang, Y.; Yao, Y.B.; Lei, X.L.; Qian, Z.J. Butyrolactone-I from coral-derived fungus Aspergillus terreus attenuates neuro-inflammatory response via suppression of NF-κB pathway in BV-2 cells. Mar. Drugs 2018, 16, 202. [Google Scholar] [CrossRef] [Green Version]
  12. Hur, J.; Jang, J.; Sim, J. A review of the pharmacological activities and recent synthetic advances of γ-butyrolactones. Int. J. Mol. Sci. 2021, 22, 2769. [Google Scholar] [CrossRef]
  13. Ibrahim, S.R.M.; Mohamed, G.A.; Ross, S.A. Aspernolides L and M, new butyrolactones from the endophytic fungus Aspergillus versicolor. Z. Nat. 2016, 72, 155–160. [Google Scholar] [CrossRef] [PubMed]
  14. Luo, Y.; Ma, H.M.; Zhang, X.Y.; He, X.; Wang, W.D.; Gang, C.; Wang, H.F.; Pei, Y.H. A new butyrolactone from Aspergillus sp. Chem. Nat. Compd. 2018, 54, 1035–1037. [Google Scholar] [CrossRef]
  15. Ma, X.X.; Liu, Y.Y.; Nie, Y.Y.; Li, Y.M.; Wang, Y.; Xue, X.Y.; Hong, P.Z.; Zhang, Y. LC-MS/MS based molecular network analysis of the effects of chemical regulation on the secondary metabolites and biological activities of a marine-derived fungal strain Aspergillus terreus C23-3. Biotechnol. Bull. Shengwu Jishu Tongbao 2021, 37, 27–41. [Google Scholar] [CrossRef]
  16. Alberts, A.W.; Chen, J.; Kuron, G.; Hunt, V.; Huff, J.; Hoffman, C.; Rothrock, J.; Lopez, M.; Joshua, H.; Harris, E.; et al. Mevinolin: A highiy potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholestesterol-lowering agent. Biochemistry 1980, 77, 3957–3961. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Yang, W.C.; Bao, H.Y.; Liu, Y.Y.; Nie, Y.Y.; Yang, J.M.; Hong, P.Z.; Zhang, Y. Depsidone derivatives and a cyclopeptide produced by marine Fungus Aspergillus unguis under chemical induction and by its plasma induced mutant. Molecules 2018, 23, 2245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Zhang, Y.; Mu, J.; Feng, Y.; Wen, L.X.; Han, J. Four chlorinated depsidones from a seaweed-derived strain of Aspergillus unguis and their new biological activities. Nat. Prod. Res. 2014, 28, 503–506. [Google Scholar] [CrossRef]
  19. Zhang, Y.; Yang, W.C.; Nei, Y.Y.; Yang, Z.Y.; Liu, Y.Y.; Song, C.; Hong, P.Z. Application of Aspergillusidone G in the Preparation of Neuroprotective Drugs. Patent Application CN11060473A, 24 December 2019. [Google Scholar]
  20. Zhang, Y.; Yang, W.C.; Nei, Y.Y.; Yang, Z.Y.; Song, C.; Hong, P.Z. Application of Depsidone Compounds in the Preparation of Neuroprotective Drugs. Patent Application CN110559290A, 13 December 2019. [Google Scholar]
  21. Sureram, S.; Kesornpun, C.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Directed biosynthesis through biohalogenation of secondary metabolites of the marine-derived fungus Aspergillus unguis. RSC Adv. 2013, 3, 1781–1788. [Google Scholar] [CrossRef]
  22. Ibrahim, S.R.M.; Mohamed, G.A.; Al Haidari, R.A.; El-Kholy, A.A.; Zayed, M.F.; Khayat, M.T. Biologically active fungal depsidones: Chemistry, biosynthesis, structural characterization, and bioactivities. Fitoterapia 2018, 129, 317–365. [Google Scholar] [CrossRef]
  23. Sureram, S.; Wiyakrutta, S.; Ngamrojanavanich, N.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Depsidones, aromatase inhibitors and radical scavenging agents from the marine-derived fungus Aspergillus unguis CRI282-03. Planta Med. 2012, 78, 582–588. [Google Scholar] [CrossRef] [PubMed]
  24. Sadorn, K.; Saepua, S.; Bunbamrung, N.; Boonyuen, N.; Komwijit, S.; Rachtawee, P.; Pittayakhajonwut, P. Diphenyl ethers and depsidones from the endophytic fungus Aspergillus unguis BCC54176. Tetrahedron 2022, 105, 132612. [Google Scholar] [CrossRef]
  25. Saetang, P.; Rukachaisirikul, V.; Phongpaichit, S.; Preedanon, S.; Sakayaroj, J.; Hadsadee, S.; Jungsuttiwong, S. Antibacterial and antifungal polyketides from the fungus Aspergillus unguis PSU-MF16. J. Nat. Prod. 2021, 84, 1498–1506. [Google Scholar] [CrossRef] [PubMed]
  26. Gyetvai, A.; Emri, T.; Takacs, K.; Dergez, T.; Fekete, A.; Pesti, M.; Pocsi, I.; Lenkey, B. Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen. FEMS. Yeast Res. 2006, 6, 1140–1148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Qiao, J.; Kontoyiannis, D.P.; Wan, Z.; Li, R.; Liu, W. Antifungal activity of statins against Aspergillus species. Med. Mycol. 2007, 45, 589–593. [Google Scholar] [CrossRef] [Green Version]
  28. Huang, Z.; Nong, X.; Zhe, R.; Wang, J.; Zhang, X.; Qi, S. Anti-HSV-1, antioxidant and antifouling phenolic compounds from the deep-sea-derived fungus Aspergillus versicolor SCSIO 41502. Bioorg. Med. Chem. Lett. 2017, 27, 787–791. [Google Scholar] [CrossRef]
  29. Johnson, L.J.; Koulman, A.; Christensen, M.; Lane, G.A.; Fraser, K.; Forester, N.; Johnson, R.D.; Bryan, G.T.; Rasmussen, S. An extracellular siderophore is required to maintain the mutualistic interaction of Epichloe festucae with Lolium perenne. PLoS Pathog. 2013, 9, 332–351. [Google Scholar] [CrossRef] [Green Version]
  30. Bunbamrung, N.; Intaraudom, C.; Dramae, A.; Komwijit, S.; Laorob, T.; Khamsaeng, S.; Pittayakhajonwut, P. Antimicrobial, antimalarial and anticholinesterase substances from the marine-derived fungus Aspergillus terreus BCC51799. Tetrahedron 2020, 76, 131496. [Google Scholar] [CrossRef]
  31. Yoshimi, A.; Yamaguchi, S.; Fujioka, T.; Kawai, K.; Gomi, K.; Machida, M.; Abe, K. Heterologous production of a novel cyclic peptide compound, KK-1, in Aspergillus oryzae. Front. Microbiol. 2018, 9, 690–702. [Google Scholar] [CrossRef]
  32. Nong, X.H.; Wang, Y.F.; Zhang, X.Y.; Zhou, M.P.; Xu, X.Y.; Qi, S.H. Territrem and butyrolactone derivatives from a marine-derived fungus Aspergillus terreus. Mar. Drugs. 2014, 12, 6113–6124. [Google Scholar] [CrossRef]
  33. Nie, Y.Y. Screening and Secondary Metabolite Research of Seaweeds and Marine Fungi with Anti-Alzheimer’s Disease Related Activity. Master’s Thesis, Guangdong Ocean University, Guangdong, China, 3 December 2017. [Google Scholar]
  34. Fukuda, T.; Kurihara, Y.; Kanamoto, A.; Tomoda, H. Terretonin G, a new sesterterpenoid antibiotic from marine-derived Aspergillus sp. OPMF00272. J. Antibiot. 2014, 67, 593–595. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Liu, J.; Wei, X.Y.; Kim, E.L.; Lin, X.P.; Yang, X.W.; Zhou, X.F.; Yang, B.; Jung, J.H.; Liu, Y.H. New glucosidated pyrazinoquinazoline indole alkaloids from fungus Aspergillus fumigatus derived of a jellyfish. Tetrahedron 2015, 71, 271–275. [Google Scholar] [CrossRef]
  36. Gombodorj, S.; Yang, M.H.; Shang, Z.C.; Liu, R.H.; Li, T.X.; Yin, G.P.; Kong, L.Y. New phenalenone derivatives from Pinellia ternata tubers derived Aspergillus sp. Fitoterapia 2017, 120, 72–78. [Google Scholar] [CrossRef] [PubMed]
  37. Katsuhiro, S.A.K.; Hiroshi, Y.; Shinji, F.; Takaaki, N.; Taizo, N. NF 00659A1, A2, A3, B1 and B2, novel antitumor antibiotics produced by Aspergillus sp. NF 00659. J. Antibiot. 1997, 4, 318–324. [Google Scholar] [CrossRef] [Green Version]
  38. Zhang, Y.; Li, X.M.; Wang, B.G. Nigerasperones A~C, new monomeric and dimeric naphtho-γ-pyrones from a marine alga-derived endophytic fungus Aspergillus niger EN-13. J. Antibiot. 2007, 60, 204–210. [Google Scholar] [CrossRef]
  39. Shaaban, M.; Shaaban, K.A.; Abdel-Aziz, M.S. Seven naphtho-γ-pyrones from the marine derived fungus Alternaria alternata: Structure elucidation and biological properties. Org. Med. Chem. Lett. 2012, 2, 6–14. [Google Scholar] [CrossRef] [Green Version]
  40. Priestap, H.A. New naphththopyrones from Aspergillus fonsecaeus. Tetrahedron 1984, 40, 3617–3624. [Google Scholar] [CrossRef]
  41. Liao, G.F.; Wu, P.; Xue, J.H.; Liu, L.; Li, H.X.; Wei, X.Y. Asperimides A-D, anti-inflammatory aromatic butenolides from a tropical endophytic fungus Aspergillus terreus. Fitoterapia 2018, 131, 50–54. [Google Scholar] [CrossRef]
  42. Steyn, P.S. Austamide, a new toxic metabolite from Aspergillus ustus. Tetrahedron Lett. 1971, 12, 3331–3334. [Google Scholar] [CrossRef]
  43. Malmstrøm, J. Unguisins A and B: New cyclic peptides from the marine-derived fungus Emericella unguis. J. Nat. Prod. 1999, 62, 787–789. [Google Scholar] [CrossRef]
  44. Shiono, Y.; Miyazaki, N.; Murayama, T.; Koseki, T.; Harizon; Katia, D.G.; Supratman, U.; Nakata, J.; Kakihara, Y.; Saeki, M.; et al. GSK-3β inhibitory activities of novel dichroloresorcinol derivatives from Cosmospora vilior isolated from a mangrove plant. Phytochem. Lett. 2016, 18, 122–127. [Google Scholar] [CrossRef]
  45. Rukachaisirikul, V.; Satpradit, S.; Klaiklay, S.; Phongpaichit, S.; Borwornwiriyapan, K.; Sakayaroj, J. Polyketide anthraquinone, diphenyl ether, and xanthone derivatives from the soil fungus Penicillium sp. PSU-RSPG99. Tetrahedron 2014, 70, 5148–5152. [Google Scholar] [CrossRef]
  46. Phainuphong, P.; Rukachaisirikul, V.; Phongpaichit, S.; Sakayaroj, J.; Kanjanasirirat, P.; Borwornpinyo, S.; Akrimajirachoote, N.; Yimnual, C.; Muanprasat, C. Depsides and depsidones from the soil-derived fungus Aspergillus unguis PSU-RSPG204. Tetrahedron 2018, 74, 5691–5699. [Google Scholar] [CrossRef]
  47. Elsbaey, M.; Sallam, A.; El-Metwally, M.; Nagata, M.; Tanaka, C.; Shimizu, K.; Miyamoto, T. Melanogenesis inhibitors from the endophytic fungus Aspergillus amstelodami. Chem. Biodivers. 2019, 16, e1900237. [Google Scholar] [CrossRef]
  48. Bertrand, S.; Bohni, N.; Schnee, S.; Schumpp, O.; Gindro, K.; Wolfender, J.L. Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discovery. Biotechnol. Adv. 2014, 32, 1180–1204. [Google Scholar] [CrossRef]
  49. Sweany, R.R.; Mack, B.M.; Moore, G.G.; Gilbert, M.K.; Cary, J.W.; Lebar, M.D.; Rajasekaran, K.; Daman, K.E., Jr. Genetic responses and aflatoxin inhibition during co-culture of aflatoxigenic and non-aflatoxigenic Aspergillus flavus. Toxins 2021, 13, 794. [Google Scholar] [CrossRef]
  50. Arora, D.; Gupta, P.; Jaglan, S.; Roullier, C.; Grovel, O.; Bertrand, S. Expanding the chemical diversity through microorganisms co-culture: Current status and outlook. Biotechnol. Adv. 2020, 40, 734–750. [Google Scholar] [CrossRef]
  51. Boruta, T.; Scigaczewska, A.; Bizukojc, M. “Microbial Wars” in a stirred tank bioreactor: Investigating the co-cultures of Streptomyces rimosus and Aspergillus terreus, filamentous microorganisms equipped with a rich arsenal of secondary metabolites. Front. Bioeng. Biotechnol. 2021, 9, 713639. [Google Scholar] [CrossRef]
  52. Liu, C.; Kakeya, H. Cryptic chemical communication: Secondary metabolic responses revealed by microbial co-culture. Chem. Asian J. 2020, 15, 327–337. [Google Scholar] [CrossRef]
  53. Fischer, J.; Muller, S.Y.; Netzker, T.; Jager, N.; Gacek-Mattews, A.; Pezzini, F.; Schoeler, H.; Reichelt, M.; Gershenzon, J.; Krespach, M.K.; et al. Chromatin mapping identifies BasR, a key regulator of bacteria-triggered production of fungal secondary metabolites. eLife. 2018, 7, 69–104. [Google Scholar] [CrossRef]
  54. Glauser, G.; Gindro, K.; Fringeli, J.; Joffrey, D.J.P.; Rudaz, S.; Wolfender, J.L. Differential analysis of mycoalexins in confrontation zones of grapevine fungal pathogens by ultrahigh pressure liquid chromatography/time-of-flight mass spectrometry and capillary nuclear magnetic resonance. J. Agric. Food Chem. 2009, 57, 1127–1134. [Google Scholar] [CrossRef] [PubMed]
  55. Yang, X.L.; Awakawa, T.; Wakimoto, T.; Abe, I. Induced biosyntheses of a novel butyrophenone and two aromatic polyketides in the plant pathogen Stagonospora nodorum. Nat. Prod. Bioprospect. 2013, 3, 141–144. [Google Scholar] [CrossRef]
  56. Ariawan, A.D.; Webb, J.E.A.; Howe, E.N.W.; Gale, P.A.; Thordarson, P.; Hunter, L. Cyclic peptide unguisin A is an anion receptor with high affinity for phosphate and pyrophosphate. Org. Biomol. Chem. 2017, 15, 2962–2967. [Google Scholar] [CrossRef] [PubMed]
  57. Lian, Z.R.; Wang, J.T. Competition between prorocentrum donghaiense and heterotrophic bacteria for phosphate. Acta Hydrobiol. Sin. Shuisheng Shengwu Xuebao 2010, 36, 663–668. [Google Scholar] [CrossRef]
  58. Chiu, C.H.; Paszkowski, U. Mechanisms and impact of symbiotic phosphate acquisition. Cold Spring Harbor Perspect. Biol. 2019, 11, 603–636. [Google Scholar] [CrossRef]
  59. Yang, Y.; Li, B.Q.; Cheng, C.P.; Liang, J.R.; Yang, Q.L.; Gao, Y.H. Interspecies competition between Woloszynskia sp. and Alexandrium tamarense based on phosphate concentration and initial cell density. J. Xiamen Univ. Xiamen Daxue Xuebao 2008, 47, 163–172. [Google Scholar]
  60. Yamanaka, K.; Oikawa, H.; Ogawa, H.; Hosono, K.; Shinmachi, F.; Takano, H.; Sakuda, S.; Beppu, T.; Ueda, K. Desferrioxamine E produced by Streptomyces griseus stimulates growth and development of Streptomyces tanashiensis. Microbiology 2005, 151, 2899–2905. [Google Scholar] [CrossRef]
  61. Macreadie, I.G.; Johnson, G.; Schlosser, T.; Macreadie, P.I. Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol. Lett. 2006, 262, 9–13. [Google Scholar] [CrossRef] [Green Version]
  62. Tavakkoli, A.; Johnston, T.P.; Sahebkar, A. Antifungal effects of statins. J. Pharmacol. Ther. 2020, 208, 83–123. [Google Scholar] [CrossRef]
  63. Boruta, T.; Milczarek, I.; Bizukojc, M. Evaluating the outcomes of submerged co-cultivation: Production of lovastatin and other secondary metabolites by Aspergillus terreus in fungal co-cultures. Appl. Microbiol. Biotechnol. 2019, 103, 5593–5605. [Google Scholar] [CrossRef] [Green Version]
  64. Boruta, T.; Marczyk, A.; Rychta, K.; Przydacz, K.; Bizukojc, M. Confrontation between Penicillium rubens and Aspergillus terreus: Investigating the production of fungal secondary metabolites in submerged co-cultures. J. Biosci. Bioeng. 2020, 130, 503–513. [Google Scholar] [CrossRef] [PubMed]
  65. Wang, C.; Lu, H.; Lan, J.; Zaman, K.H.A.; Cao, S. A review: Halogenated compounds from marine fungi. Molecules 2021, 26, 458. [Google Scholar] [CrossRef] [PubMed]
  66. Dean, F.M.; Robertson, A.; Roberts, J.C.; Rapeb, K.B. Nidulin and ‘ustin’: Two chlorine-containing metabolic products of Aspergillus nidulans. Nature 1953, 172, 344. [Google Scholar] [CrossRef] [PubMed]
  67. Kawahara, N.; Nakajima, S.; Satoh, Y.; Yamazaki, M.; Kawai, K. Studies on fungal products. XVIII. Isolation and structures of a new fungal depsidone related to nidulin and a new phthalide from Emericella unguis. Chem. Pharm. Bull. 1988, 36, 1970–1975. [Google Scholar] [CrossRef] [Green Version]
  68. Isaka, M.; Yangchum, A.; Supothina, S.; Veeranondha, S.; Komwijit, S.; Phongpaichit, S. Semisynthesis and antibacterial activities of nidulin derivatives. J. Antibiot. 2019, 72, 181–184. [Google Scholar] [CrossRef]
  69. Vala, A.K.; Dave, B.P.; Dube, H.C. Chemical characterization and quantification of siderophores produced by marine and terrestrial Aspergilli. Can. J. Microbiol. 2006, 52, 603–607. [Google Scholar] [CrossRef]
  70. Renshaw, J.C.; Robson, G.D.; Trinci, A.P.J.; Wiebe, M.G.; Livens, F.R.; Collison, D.; Taylor, R.J. Fungal siderophores: Structures, functions and applications. Mycol. Res. 2002, 106, 1123–1142. [Google Scholar] [CrossRef]
  71. Nie, Y.Y.; Yang, W.C.; Liu, Y.Y.; Yang, J.M.; Lei, X.L.; Gerwick, W.H.; Zhang, Y. Acetylcholinesterase inhibitors and antioxidants mining from marine fungi: Bioassays, bioactivity coupled LC–MS/MS analyses and molecular networking. Mar. Life Sci. Technol. 2020, 2, 386–397. [Google Scholar] [CrossRef]
  72. Magaldi, S.; Mata-Essayag, S.; Hartung de Capriles, C.; Perez, C.; Colella, M.T.; Olaizola, C.; Ontiveros, Y. Well diffusion for antifungal susceptibility testing. Int. J. Infect. Dis. 2004, 8, 39–45. [Google Scholar] [CrossRef] [Green Version]
  73. Panda, S.K. Ethno-medicinal uses and screening of plants for antibacterial activity from Similipal Biosphere Reserve, Odisha, India. J. Ethnopharmacol. 2014, 151, 158–175. [Google Scholar] [CrossRef]
Figure 1. The morphology of axenic cultures and co-cultures in different experiments (28 days in total). (G1G7), respectively, represent: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), livT-livU (G7).
Figure 1. The morphology of axenic cultures and co-cultures in different experiments (28 days in total). (G1G7), respectively, represent: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), livT-livU (G7).
Antibiotics 11 00513 g001
Figure 2. HPTLC fingerprints of the axenic and co-cultural extracts. (A) is the UV images of experiments G1–G7 under 254 nm (the sample numbers were marked with pencil below the starting line). (B) is the UV images of G1–G7 under 365 nm. (C) is the image of sulfuric acid-anisaldehyde colorized plate of G1–G7. (D) is the image of potassium ferricyanide-ferric chloride (PFFC) colorized plate of G1–G7. (E) is the DPPH free radical scavenging autographic image of G1–G7. (F) is acetylcholinesterase inhibitory bioautographic image of G1–G7. The developing agent was chloroform:methanol = 20:1 (v/v). The rulers beside the TLC plate are taken as references for Rf value calculation. The yellow or red arrows mark the new metabolites produced only under co-cultural conditions.
Figure 2. HPTLC fingerprints of the axenic and co-cultural extracts. (A) is the UV images of experiments G1–G7 under 254 nm (the sample numbers were marked with pencil below the starting line). (B) is the UV images of G1–G7 under 365 nm. (C) is the image of sulfuric acid-anisaldehyde colorized plate of G1–G7. (D) is the image of potassium ferricyanide-ferric chloride (PFFC) colorized plate of G1–G7. (E) is the DPPH free radical scavenging autographic image of G1–G7. (F) is acetylcholinesterase inhibitory bioautographic image of G1–G7. The developing agent was chloroform:methanol = 20:1 (v/v). The rulers beside the TLC plate are taken as references for Rf value calculation. The yellow or red arrows mark the new metabolites produced only under co-cultural conditions.
Antibiotics 11 00513 g002
Figure 3. The antimicrobial activities of representative co-cultures (G3 & G4). The figures (ah) for G3 & G4 are the antimicrobial results against MRSA, Bacillus subtilis, Pseudomonas aeruginosa, Vibro parahemolyticus, V. alginolyticus, Shewanella putrefaciens, Yersinia pseudotuberculosis, and Candida albicans, sequentially. For some relatively weak inhibition zones, circles in dash lines were used to mark them.
Figure 3. The antimicrobial activities of representative co-cultures (G3 & G4). The figures (ah) for G3 & G4 are the antimicrobial results against MRSA, Bacillus subtilis, Pseudomonas aeruginosa, Vibro parahemolyticus, V. alginolyticus, Shewanella putrefaciens, Yersinia pseudotuberculosis, and Candida albicans, sequentially. For some relatively weak inhibition zones, circles in dash lines were used to mark them.
Antibiotics 11 00513 g003
Figure 4. The HPLC traces of the culture extracts detected under the UV wavelength of 280 nm and the UV spectra for the featured peaks. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 4. The HPLC traces of the culture extracts detected under the UV wavelength of 280 nm and the UV spectra for the featured peaks. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Antibiotics 11 00513 g004
Figure 5. The HPLC traces of the culture extracts detected under the UV wavelength of 360–370 nm and the UV spectra for the featured peaks. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 5. The HPLC traces of the culture extracts detected under the UV wavelength of 360–370 nm and the UV spectra for the featured peaks. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Antibiotics 11 00513 g005
Figure 6. The LC-MS traces (base peak chromatographies, BPC) under positive ion mode of the culture extracts. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 6. The LC-MS traces (base peak chromatographies, BPC) under positive ion mode of the culture extracts. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Antibiotics 11 00513 g006
Figure 7. The LC-MS traces (base peak chromatographies, BPC) under negative ion mode of the culture extracts. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 7. The LC-MS traces (base peak chromatographies, BPC) under negative ion mode of the culture extracts. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Antibiotics 11 00513 g007
Figure 8. Annotated compound structures for the peaks 1–15. The asterisks (*) mark hits from databases with relatively higher reliability based on their similarities, including not only molecular weights, but also at least one of the following characteristics like GNPS MS2 similarity, UV features, isotopic patterns (for chlorinated compounds), and taxonomy, to the featured peaks. Compounds 10-1 and 10-2 represent two alternative annotations for peak 10 (see Table 3 for further data on each of these annotations). This terminology also applies for the other base compound numbers.
Figure 8. Annotated compound structures for the peaks 1–15. The asterisks (*) mark hits from databases with relatively higher reliability based on their similarities, including not only molecular weights, but also at least one of the following characteristics like GNPS MS2 similarity, UV features, isotopic patterns (for chlorinated compounds), and taxonomy, to the featured peaks. Compounds 10-1 and 10-2 represent two alternative annotations for peak 10 (see Table 3 for further data on each of these annotations). This terminology also applies for the other base compound numbers.
Antibiotics 11 00513 g008
Figure 9. The GNPS molecular network based on positive ion MS/MS spectral similarity, showing a selection of amplified clusters. The nodes display the measured average masses of the molecular ions with identical MS/MS spectra. The sizes of the nodes reflect the relative amount of the corresponding compounds. The different colors of sections in the nodes represent different samples, i.e., Antibiotics 11 00513 i001: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7), respectively. (A) is an enlarged cluster for statins including the sodiated ion of peak 7 (lovastatin). (B) is an enlarged cluster containing a possible fusarine-like siderophore. (C) is an enlarged cluster containing heme B. (D) is an enlarged cluster containing protonated ion of peak 7. (E) is an enlarged cluster containing peak 6 (territrem B). (F) conclude two nodes annotated as a diketopiperazine and a simvastatin fragment. (G) is a node annotated as a cyclopeptide.
Figure 9. The GNPS molecular network based on positive ion MS/MS spectral similarity, showing a selection of amplified clusters. The nodes display the measured average masses of the molecular ions with identical MS/MS spectra. The sizes of the nodes reflect the relative amount of the corresponding compounds. The different colors of sections in the nodes represent different samples, i.e., Antibiotics 11 00513 i001: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7), respectively. (A) is an enlarged cluster for statins including the sodiated ion of peak 7 (lovastatin). (B) is an enlarged cluster containing a possible fusarine-like siderophore. (C) is an enlarged cluster containing heme B. (D) is an enlarged cluster containing protonated ion of peak 7. (E) is an enlarged cluster containing peak 6 (territrem B). (F) conclude two nodes annotated as a diketopiperazine and a simvastatin fragment. (G) is a node annotated as a cyclopeptide.
Antibiotics 11 00513 g009
Figure 10. The GNPS molecular network based on negative ion MS/MS spectral similarity showing a selection of amplified clusters. The nodes display the measured average masses of the molecular ions with identical MS/MS spectra. The sizes of the nodes reflect the relative amount of the corresponding compounds. The different colors of sections in the nodes represent different samples, i.e., Antibiotics 11 00513 i002: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7), respectively. (A) is an enlarged cluster containing peak 15 (nidulin). (B) is an enlarged cluster containing nornidulin.
Figure 10. The GNPS molecular network based on negative ion MS/MS spectral similarity showing a selection of amplified clusters. The nodes display the measured average masses of the molecular ions with identical MS/MS spectra. The sizes of the nodes reflect the relative amount of the corresponding compounds. The different colors of sections in the nodes represent different samples, i.e., Antibiotics 11 00513 i002: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7), respectively. (A) is an enlarged cluster containing peak 15 (nidulin). (B) is an enlarged cluster containing nornidulin.
Antibiotics 11 00513 g010
Figure 11. The interpretation of MS/MS spectrum of peak 4 (cyclopeptide unguisin A).
Figure 11. The interpretation of MS/MS spectrum of peak 4 (cyclopeptide unguisin A).
Antibiotics 11 00513 g011
Table 1. The total extract amounts and antimicrobial activities from experiments G1–G7, which were measured using the Oxford Cup method (dosage: 200 mL/well, concentration = 1 mg/mL, concentration for both controls = 0.1 mg/mL, n = 4).
Table 1. The total extract amounts and antimicrobial activities from experiments G1–G7, which were measured using the Oxford Cup method (dosage: 200 mL/well, concentration = 1 mg/mL, concentration for both controls = 0.1 mg/mL, n = 4).
Sample
Number
Total Sample
Amount
(Yield: mg/flask)
Diameters of Inhibition Zones Against Indicator Microbes (mm) #
MRSABacillus subtilisPseudomonus
aeruginosa
Vibro
parahemolyticus
Vibro
alginolyticus
Shewanella
putrefaciens
Yersinia
pseudotuberculosis
Candida
albicans
axU (G1)345 ± 4015.7 ± 0.613.2 ± 0.514.0 ± 0.918.6 ± 0.917.8 ± 0.817.1 ± 1.2-13 ± 0.5
axT (G2)624 ± 10---7.3 ± 0.48.1 ± 0.69.3 ± 0.5--
iacU-livT (G3)560 ± 20-7.5 ± 0.88.9 ± 0.911.8 ± 0.47.3 ± 0.97.1 ± 0.5-14.2 ± 0.7
livU-livT (G4)309 ± 3013.0 ± 0.415.7 ± 0.515.6 ± 1.017.8 ± 0.616.2 ± 0.617.4 ± 0.5-11.7 ± 0.5
livU/livT (G5)420 ± 8010.2 ± 0.614.3 ± 0.714.2 ± 0.7-14.3 ± 0.518 ± 0.8-13.0 ± 0.8
iacT-livU (G6)440 ± 20-7.0 ± 0.4--9.6 ± 0.610.4 ± 0.8-12.3 ± 0.5
livT-livU (G7)638 ± 408.1 ± 0.3--8. 1 ± 0.9---9.2 ± 0.7
Ampicillin-14.1 ± 0.417.5 ± 0.219.7 ± 0.524.1 ± 0.918.6 ± 0.416.1 ± 0.611.3 ± 0.2-
Ketoconazole--------16.3 ± 0.8
#: three times average ± standard deviation; -: no activity or very weak activity.
Table 2. The changing folds for the yields of the differential peaks.
Table 2. The changing folds for the yields of the differential peaks.
Feature Peak NumberG3(iacU-livT)G4(livU-livT)G5(livU/livT)G6(iacT-livU)G7(livT-livU)
G2(axT)10.14<0.010.020.13↑1.58
2↑1.59↑1.96↑2.11↑2.24↑2.46
5↓0.230.020.08↑1.49↑3.49
60.12<0.010.11↓0.7↓0.72
7↓0.210.08↑3.57↑3.15↑4.42
8↓0.520.198.417.3110.47
90.020.06<0.010.080.05
10↓<0.01↓<0.010.09↓0.64↑1.36
110.020.04↓0.52↑1.33↑3.03
12↓0.20.060.080.02↓0.57
130.030.020.14↓0.27↓0.91
G1(axU)2↑4.575.666.076.457.09
30.05↑3.46↑3.08<0.010.01
4↑3.65↑3.48↓0.780.090.14
15↓0.23↓0.56↓0.50.140
1400↑113.391.89
Note: : Production decreased fivefold and more; ↓: Production decreased less than fivefold; : Production increased fivefold and more; ↑: Production increased less than fivefold; : New metabolite (in large quantities) in co-culture; ↑: New metabolite (in small amounts) in co-culture.
Table 3. Multiple database mining of the main peaks that show remarkably different yields in base peak chromatographies (BPCs) of their LC-MS profiles using positive and negative modes of ionization.
Table 3. Multiple database mining of the main peaks that show remarkably different yields in base peak chromatographies (BPCs) of their LC-MS profiles using positive and negative modes of ionization.
Peak
Number
Presence in
Sample
m/z Value
Measured
Retention
Time
(min)
UV
Maximum
Measured
(nm)
Compound Hits
in Library
Molecular
Weight
in Libraries
Libraries & IDsMS2
Similarity
(Cosine)
Molecular
Formula
UV Maximum
Absportive Peaks
in Libraries/Literature (nm)
BioresourceDOIBiological
Activity
Structures Code of the
Compound Hits
1G2, G7309.10 [M + H]+
(presumed)
1.672321,4-Bis(piperidin-1-ylmethyl)piperazine-2,5-dione308.33Dictionary of Natural ProductsN/AC16H28N4O2N/A (isolate amide)A. terreusN/AN/A1-1 *
2G1–G7679.59 [M + H]+
677.88 [M − H]
2.872313β-(β-D-glucopyranosyloxy)olean-12-ene-23,28,30-trioic acid678.81NMRDATA, 1331571; Natural Product Atlas, NPA026397; Pubchem, 146682840N/AC36H54O12N/A (isolate double bonds)A. amstelodami10.1002/cbdv.201900237anti-melanogenic and anti-allergic activity2-1 *
3G1, G4, G5777.38 [M + H]+
775.34 [M − H]
6.40231Aspergilasine B775.84NMRDATA, 999923; Dictionary of Natural ProductsN/AC42H49NO13202, 240A. flavipes QCS1210.1021/acs.orglett.7b02146no inhibitory activities againest seven cancer cell lines up to a concentration of 40μM.3-1
4G1, G3–G7759.36 [M + H]+
757.60 [M − H]
7.81230,
280
Unguisin A758.92NMRDATA, 29553N/AC40H54N8O7290, 281, 274, 219A. unguis10.1021/np980539z;10.1039/C7OB00316Amoderately inhibited Staphylococcus aureus;as an anion receptor with high affinity for phosphate and pyrophosphate4-1 *
5G2, G7585.27 [M + H]+
583.24 [M − H]
9.30229,
264,
280,
422
Aspergilol A584.62NMRDATA, 895659; Pubchem, 132915662; Natural Product Atlas, NPA009011; Dictionary of Natural ProductsN/AC34H32O9196, 293, 452A. versicolor10.1016/j.tet.2015.10.038possessing antioxidant activities5-1
Aspergilol B584.61Dictionary of Natural ProductsN/AC34H32O9194, 293, 462Aspergillus10.1016/j.tet.2015.10.038possessing antioxidant activities5-2
Aspergilol G584.61Dictionary of Natural ProductsN/AC34H32O9206, 265, 295, 458Aspergillus10.1016/J.BMCL.2017.01.032N/A5-3 *
6G2, G6, G7527.22 [M + H]+9.99240,
312,
369,
417
Territrem B526.57GNPS, CCMSLIB000054360750.70C29H34O9195, 220, 236, 330, 284A. terreus10.3390/md12126113strong inhibitory activity against acetylcholinesterase, potent antifouling activity6-1 *
526.57Dictionary of Natural ProductsN/A
7G2, G5–G7427.26 [M + Na]+11.80243, 275, 313, 364Lovastatin404.54GNPS, CCMSLIB000008522140.76C24H36O5231, 238, 247A. terreus10.1080/10826068.2020.1805624the competitive inhibitors of the enzyme hydroxy-methyl-glutaryl coenzyme A (HMG-CoA) reductase7-1 *
404.54Dictionary of Natural ProductsN/A
8G5–G7459.31 [M + H]+
(presumed)
12.15246,
285
Unannotated statinN/AN/AN/AN/AN/AN/AN/AN/AN/A
Aspernolide D458.46NMRDATA, 152713; Pubchem, 46930025; Natural Product Atlas, NPA003511N/AC24H26O9290A. terreus RCBC100210.1248/cpb.58.1221Inactive against all bacterial strains8-1
9G2, G7507.38 [M + H]+
(presumed)
16.26N/A (no obvious absorption)Terretonin G506.58NMRDATA, 809567; Dictionary of Natural ProductsN/AC27H38O9End absorptionAspergillus sp. OPMF0027210.1038/ja.2014.46Moderate antimicrobial activity against Gram-positive bacteria9-1 *
10G2, G5–G71106.49 [M + Na]+
1082.38 [M − H]
17.78272,
350
Epichloenin A1083.15Dictionary of Natural ProductsN/AC46H74N12O18N/A (containing a,b-unsaturated amides)Epichloe¨ festucae10.1371/journal.ppat.1003332as an important molecular/cellular signal for controlling fungal growth and hence the symbiotic interaction.10-1 *
Astalluminoxide1084.22Natural Product Atlas, NPA032177N/AC60H66AlN9O9201, 222, 272, 349A. terreus BCC5179910.1016/j.tet.2020.131496moderate to weak cytotoxicity against both cancerous and non-cancerous cells.10-2 *
11G2, G5–G71135.35 [M + Na]+18.20273,
346
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
12G2, G7606.07 [M − H]
(presumed)
2.16231N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
13G2, G7362.92 [M − H]
(presumed)
8.87226,
264,
278,
420
Austamide363.41Dictionary of Natural ProductsN/AC21H21N3O3234, 256, 282, 392A.ustus10.1016/s0040-4039(01)97170-9toxic to ducklings13-1 *
Circumdatin B363.37Dictionary of Natural ProductsN/AC20H17N3O4284, 358A. ochraceus10.1021/jo981536uInactive in the assay against NCI’s 60 cancer cell line panel13-2
Asperimide A363.41Natural Product Atlas, NPA028229N/AC22H21NO4229, 278, 360A.terreus10.1016/j.fitote.2018.10.011not found exhibited cytotoxicity13-3 *
14G6, G7367.19 [M − H]
(presumed) (367.19:369.11:371.19 = 9:6:1, in intensity) revealing to be dichlorinated compound
11.54244, 275, 313, 361Cosmochlorin A369.24Dictionary of Natural Products; Natural Product Atlas, NPA030107N/AC18H18Cl2O4323Cosmospora vilior IM2-15510.1016/j.phytol.2016.09.007moderate antimicrobial activity against gram-positive bacteria and fungi;
partially restored the growth inhibition caused by hyperactivated Ca2+-signaling in mutant yeast and showed GSK-3b inhibition
14-1 *
Cosmochlorin B369.24Dictionary of Natural Products; Natural Product Atlas, NPA030108N/AC18H18Cl2O4230, 290Cosmospora vilior IM2-15510.1016/j.phytol.2016.09.007Inactive against microbes;
similar restoring the growth inhibition activity to cosmochlorin A, promoting osteoclast formation
14-2 *
Cosmochlorin C369.24Dictionary of Natural Products; Natural Product Atlas, NPA030109N/AC18H18Cl2O4323Cosmospora vilior IM2-15510.1016/j.phytol.2016.09.007Similar antimicrobial activity to cosmochlorin A14-3 *
Penicillixanthone369.15Dictionary of Natural Products; Natural Product Atlas, NPA008373N/AC16H10Cl2O6230, 294, 369Penicillium sp. PSU-RSPG9910.1016/j.tet.2014.05.105No antimycobacterial and cytotoxic activities14-4 *
15G1, G3–G6441.07 [M − H]
(441.07:443.02:444.99:446.12 = 27:27:9:1, in intensity)
13.50237,
264
Nidulin443.70GNPS, CCMSLIB000054360770.70C20H17Cl3O5267A. unguis10.1055/s-0031-1298228
 
10.1080/14786419.2013.879305
aromatase inhibitory and antimicrobial
and DNA damaging activities
15-1 *
Pubchem, 6450195; Dictionary of Natural ProductsN/A
N/A: indicates not applicable or with no record or having limited accessibility. Compounds can be found by name in the Dictionary of Natural Product online database with more details and ID numbers. The asterisks (*) mark hits from databases with relatively higher reliability based on their similarities, including not only molecular weights, but also at least one of the following characteristics, like GNPS MS2 similarity, UV features, isotopic patterns (for chlorinated compounds), and taxonomy, to the featured peaks.
Table 4. Chromatographic analysis conditions.
Table 4. Chromatographic analysis conditions.
Injection Volume (μL)Elution ConditionsFlow Rate (mL/min)
Time (min)Proportion
250.00–1.0030% ACN-H2O0.6
1.00–10.0030–99% ACN-H2O
10.00–16.0099% ACN-H2O
16.00–16.2099–30% ACN-H2O
16.20–20.0030% ACN-H2O
Note: The Mobile phase contained 0.1% formic acid.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, Y.; Glukhov, E.; He, Y.; Liu, Y.; Zhou, L.; Ma, X.; Hu, X.; Hong, P.; Gerwick, W.H.; Zhang, Y. Secondary Metabolite Variation and Bioactivities of Two Marine Aspergillus Strains in Static Co-Culture Investigated by Molecular Network Analysis and Multiple Database Mining Based on LC-PDA-MS/MS. Antibiotics 2022, 11, 513. https://doi.org/10.3390/antibiotics11040513

AMA Style

Wang Y, Glukhov E, He Y, Liu Y, Zhou L, Ma X, Hu X, Hong P, Gerwick WH, Zhang Y. Secondary Metabolite Variation and Bioactivities of Two Marine Aspergillus Strains in Static Co-Culture Investigated by Molecular Network Analysis and Multiple Database Mining Based on LC-PDA-MS/MS. Antibiotics. 2022; 11(4):513. https://doi.org/10.3390/antibiotics11040513

Chicago/Turabian Style

Wang, Yuan, Evgenia Glukhov, Yifan He, Yayue Liu, Longjian Zhou, Xiaoxiang Ma, Xueqiong Hu, Pengzhi Hong, William H. Gerwick, and Yi Zhang. 2022. "Secondary Metabolite Variation and Bioactivities of Two Marine Aspergillus Strains in Static Co-Culture Investigated by Molecular Network Analysis and Multiple Database Mining Based on LC-PDA-MS/MS" Antibiotics 11, no. 4: 513. https://doi.org/10.3390/antibiotics11040513

APA Style

Wang, Y., Glukhov, E., He, Y., Liu, Y., Zhou, L., Ma, X., Hu, X., Hong, P., Gerwick, W. H., & Zhang, Y. (2022). Secondary Metabolite Variation and Bioactivities of Two Marine Aspergillus Strains in Static Co-Culture Investigated by Molecular Network Analysis and Multiple Database Mining Based on LC-PDA-MS/MS. Antibiotics, 11(4), 513. https://doi.org/10.3390/antibiotics11040513

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop